Evaluation of hepatitis B virus in clinical trials of baricitinib in rheumatoid arthritis

BACKGROUND: Reactivation of hepatitis B virus (HBV) replication is a well-recognised complication in patients receiving disease-modifying anti-rheumatic drugs (DMARDs) for rheumatoid arthritis (RA). Limited data exist on HBV reactivation among patients with RA treated with janus kinase (JAK) inhibit...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:RMD Open
Asıl Yazarlar: Harigai, Masayoshi, Winthrop, Kevin, Takeuchi, Tsutomu, Hsieh, Tsu-Yi, Chen, Yi-Ming, Smolen, Josef S, Burmester, Gerd, Walls, Chad, Wu, Wen-Shuo, Dickson, Christina, Liao, Ran, Genovese, Mark C
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Publishing Group 2020
Konular:
Rheumatoid Arthritis
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7046961/
https://ncbi.nlm.nih.gov/pubmed/32098857
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2019-001095
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller